These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12082547)
1. Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector. Lee J; Hampl M; Albert P; Fine HA Neoplasia; 2002; 4(4):312-23. PubMed ID: 12082547 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289 [TBL] [Abstract][Full Text] [Related]
3. [Adenoviral vector expressing the TRAIL gene driven by the hTERT promoter]. Jacob D; Davis J; Schumacher G; Bahra M; Neuhaus P; Fang B Z Gastroenterol; 2004 Dec; 42(12):1363-70. PubMed ID: 15592959 [TBL] [Abstract][Full Text] [Related]
4. Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft. Huang X; Lin T; Gu J; Zhang L; Roth JA; Stephens LC; Yu Y; Liu J; Fang B Gene Ther; 2002 Oct; 9(20):1379-86. PubMed ID: 12365003 [TBL] [Abstract][Full Text] [Related]
5. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes. Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy in colon cancer cells with a fiber-modified adenovector expressing the TRAIL gene driven by the hTERT promoter. Jacob D; Bahra M; Schumacher G; Neuhaus P; Fang B Anticancer Res; 2004; 24(5A):3075-9. PubMed ID: 15517918 [TBL] [Abstract][Full Text] [Related]
8. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector. Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667 [TBL] [Abstract][Full Text] [Related]
9. Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells. Jacob D; Schumacher G; Bahra M; Davis J; Zhu HB; Zhang LD; Teraishi F; Neuhaus P; Fang BL World J Gastroenterol; 2005 May; 11(17):2552-6. PubMed ID: 15849810 [TBL] [Abstract][Full Text] [Related]
10. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter. Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line. Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894 [TBL] [Abstract][Full Text] [Related]
12. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766 [TBL] [Abstract][Full Text] [Related]
13. Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene. Huang X; Lin T; Gu J; Zhang L; Roth JA; Liu J; Fang B Int J Oncol; 2003 Jun; 22(6):1241-5. PubMed ID: 12738989 [TBL] [Abstract][Full Text] [Related]
14. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells. Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545 [TBL] [Abstract][Full Text] [Related]
15. Cancer gene therapy using a novel secretable trimeric TRAIL. Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699 [TBL] [Abstract][Full Text] [Related]
16. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Voelkel-Johnson C; King DL; Norris JS Cancer Gene Ther; 2002 Feb; 9(2):164-72. PubMed ID: 11857034 [TBL] [Abstract][Full Text] [Related]
17. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism]. Tang YX; Chen Y; Gu JF; Qi R; Zou WG; Jiang LL; Liu XY Ai Zheng; 2005 May; 24(5):536-42. PubMed ID: 15890093 [TBL] [Abstract][Full Text] [Related]
18. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Armeanu S; Lauer UM; Smirnow I; Schenk M; Weiss TS; Gregor M; Bitzer M Cancer Res; 2003 May; 63(10):2369-72. PubMed ID: 12750253 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand. Germano IM; Uzzaman M; Benveniste RJ; Zaurova M; Keller G J Neurosurg; 2006 Jul; 105(1):88-95. PubMed ID: 16871882 [TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model. Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]